Sotera Health Company (SHC) Fair Value 2026

SHC · Services-Misc Health & Allied Services, NEC ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

8.1 /10

32 fundamental signals · 11 models active

Value Trap Risk

SAFE (12/100)

Quick Summary — As of 2026-07-13, Sotera Health Company (SHC) trades at $18.17, approximately 2364% above CirclFi’s Bayesian DCF fair value of $0.74. QOC: 8.1/10. Value Trap Risk: 12/100 (SAFE). 11/13 models active.

Key Facts

Ticker
SHC
Price
$18.17
Quality Score
8.1/10
Value Trap Risk
12/100
Models Active
11/13
Last Updated
Strength: Quality Score of 8.1/10 indicates strong fundamentals
Risk: Majority of models suggest overvaluation

Valuation Matrix

11 Intrinsic Value Models vs. Current Price ($18.17)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
High Conviction
$0.74 -95.9%
CUCE Ensemble
Low Conviction
$6.03 -66.8%
First Chicago
High Conviction
$1.80 -90.1%
Markov DDM
High Conviction
$2.21 -87.8%

Unlock the Full Matrix

Access 7 additional models including EROIC Spread, ML-RIV, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 11 Models →

Cancel anytime · No contracts · Instant access

What Is Sotera Health Company (SHC) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Sotera Health Company's intrinsic value is estimated at $5.78. Trading at its current price of $18.17, the valuation engine raises significant caution: 10 of 11 models flag downside risk, projecting an average implied return of -68.2%. The most optimistic model, PWERM, places fair value at $18.51 (+1.9%), while Bayesian DCF — the most conservative — estimates $0.74 (-95.9%). This +97.8% gap reflects genuine analytical uncertainty about Sotera Health Company's intrinsic worth. Among models with highest confidence, Markov DDM lean bearish — adding weight to the bearish side of the thesis.

What Do the Models Say About SHC?

11 of 13 models are currently active for SHC. Of these, 1 model suggests upside while 10 models suggest overvaluation. The Bayesian DCF estimates SHC's intrinsic value at $0.74, implying -95.9% downside from the current price. See which stocks rank higher →

How Does SHC Rank in Services-Misc Health & Allied Services, NEC?

Among 11 Services-Misc Health & Allied Services, NEC stocks, SHC ranks #2 by Quality of Company score. CirclFi's QOC score of 8.1/10 evaluates 32 fundamental signals. A score of 8.1 places SHC in the top tier.

Sotera Health Company operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is SHC a Value Trap?

CirclFi's Value Trap algorithm assigns SHC a score of 12/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

11 of 13 models are active for Sotera Health Company. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Sotera Health Company scores 8.1 out of 10 on our 32-signal quality assessment, a strong rating that demonstrates strong fundamentals across the majority of our quality signals. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +97.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every SHC valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across SHC's 11 active models, average confidence is 49%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Sotera Health Company Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Services-Misc Health & Allied Services, NEC Stocks Should You Also Analyze?

8 related Services-Misc Health & Allied Services, NEC stocks with 13-model coverage

Read investment analysis: PGNY · VMD · DVA · CCEL · BRTX

Frequently Asked Questions About Sotera Health Company

What is Sotera Health Company's intrinsic value in 2026?

Based on CirclFi's 13-model analysis, Sotera Health Company (SHC) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $0.74. The Quality of Company score is 8.1/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is SHC overvalued or undervalued right now?

At $18.17, 1 of 11 active models suggest SHC may be undervalued, while 10 indicate potential overvaluation. The assessment depends on which methodology best fits Sotera Health Company's business model in Services-Misc Health & Allied Services, NEC.

What does a Quality of Company score of 8.1 mean for SHC?

Sotera Health Company's QOC of 8.1/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on SHC?

CirclFi analyzes SHC with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 11 of 13 are active for this stock. Read the full methodology →

Is SHC a value trap in 2026?

Sotera Health Company's Value Trap score is 12/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 11 mathematical frameworks give you clarity on SHC.

Unlock All 11 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access